Abbott Laboratories Corporation

Other

Jin-Zhou Liu

Joseph P Schaller

Milo Duane Hilty

Steven N Anderson

Melinda Guzman-Harty

Terry Bruce Mazer

Lisa Ann Reaves

Theresa Siu-Ling Lee

Theresa Siu-Ling Wai Lee

Theresa Sui-Ling Wai Lee

Steven Neal Anderson

Jonathan A Meulbroek

Patricia Joan Ewing

Jill M Lamm

Tammy Marie Bowman

A nasal-nasopharyngeal-cleaning (NNC) system is disclosed for removing harmful substances from a human's nasal and nasopharyngeal cavities. Harmful substances herein include infectious agents, chemicals, dust, small particles and dirt deposits in nasal cavities and in the nasopharynx. The NNC system includes a NNC solution, a solution container, a liquid transfer tube, a valve means and a flat-head nostril fitting. The two-step cleaning process comprises cleaning the nasal cavity first with the NNC system and then cleaning the nasopharyngeal cavity with the NNC system.

Nasal-nasopharyngeal cleaning system

A nutritional formulation containing bactericidal amounts of diacetyltartaric acid esters of mono- and diglycerides is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.

Nutritional formulations containing water-miscible lipid derivatives as antibacterial agents

A process of treating infection by a pathogenic microorganism in a subject in need of such treatment comprising the step of administering to the subject an effective antimicrobial amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacetyltartaric acid esters of mono- and diglycerides as an active antimicrobial agent are also provided.

Water-Miscible esters of mono- and diglycerides having antimicrobial

A nutritional formulation containing bacterial amounts of diacetyltartaric acid esters of mono- and diglycerides is provided. A process of inhibiting bacterial infections including the step of feeding the nutritional composition to a subject is also provided.

Nutritional formulations containing water-miscible lipid derivatives as

A process of treating infection by a pathogenic microorganism in a subject in need of such treatment including the step of administering to the subject an effective antimicrobial amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacetyltartaric acid esters of mono- and diglycerides as an active antimicrobial agent are also provided.

Water-miscible esters of mono- and diglycerides having antimicrobial

A method of treating pneumonia or other respiratory disease caused by respiratory syncytial virus, adenovirus, parainfluenza virus, or influenza virus by orally administering a liquid, preferably an infant formula, containing a virus neutralizing antibody.

Product for prevention of respiratory virus infection and method of use

The present invention provides water-miscible lipid derivatives effective to inhibit the infectious activity of pathogenic microorganisms. Preferred water-miscible lipid derivatives are diacetyltartaric acid esters of monoglycerides wherein 90 percent or more of the fatty acid content is accounted for by a single fatty acid. The fatty acid component preferably contains from 8 to 24 and, more preferably, from about 10 to about 20 carbon atoms. The fatty acid can be saturated, unsaturated or hydroxylated.

Water-miscible esters of monoglycerides having antimicrobial activity

A process of treating a bacterial infection in a subject in need of such treatment including the step of administering to the subject an effective bactericidal amount of diacetyltartaric acid esters of mono- and diglycerides is provided. Pharmaceutical compositions containing diacetyltartaric acid esters of mono- and diglycerides as an active bactericidal agent are also provided.

Water-miscible esters of mono--and diglycerides having antibacterial

A nutritional formulation containing an amount of diacetyltartaric acid esters of mono- and diglycerides effective to inhibit the infectious activity of pathogenic microorganisms is provided. A process of inhibiting the infectious activity of pathogenic microorganisms including the step of feeding the nutritional composition to a subject is also provided.

Growing community of inventors

Westerville, OH, United States of America

Jin-Zhou Liu